California Judge Upholds In-State Ban on ‘Pay-for-Delay’ Pharmaceutical Agreements, Citing Constitutional Limits on Broader Enforcement

A federal judge in California has upheld part of a new state law aimed at restricting “reverse payment” settlements between brand-name and generic drug manufacturers. The ruling came despite allegations from the Association for Accessible Medicines that the law unlawfully restricts these agreements. The judge determined that while the law’s attempt to regulate settlements beyond California’s borders conflicts with the Constitution, the provisions applicable within the state are valid. For further details, read the full report on this significant legal ruling.